Structure Therapeutics (GPCR) Other Non-Current Assets (2022 - 2026)
Quarterly Other Non-Current Assets fell 8.87% to $5.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $5.6 million through Mar 2026, down 8.87% year-over-year, with the annual reading at $717000.0 for FY2025, 85.96% down from the prior year.
Structure Therapeutics' Other Non-Current Assets history spans 5 years, with the latest figure at $5.6 million for Q1 2026.
- Other Non-Current Assets came in at $5.6 million for Q1 2026, up from $717000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $6.6 million in Q3 2025 to a low of $38000.0 in Q2 2023.
- The 5-year median for Other Non-Current Assets is $1.8 million (2024), against an average of $2.7 million.
- Year-over-year, Other Non-Current Assets plummeted 98.7% in 2023 and then surged 12870.21% in 2025.
- Structure Therapeutics' Other Non-Current Assets stood at $3.5 million in 2022, then tumbled by 98.7% to $45000.0 in 2023, then soared by 11246.67% to $5.1 million in 2024, then tumbled by 85.96% to $717000.0 in 2025, then surged by 674.76% to $5.6 million in 2026.
- Per Business Quant, the three most recent readings for GPCR's Other Non-Current Assets are $5.6 million (Q1 2026), $717000.0 (Q4 2025), and $6.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 12.40 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 60,000.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1.26 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 2.13 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 63.55 Mn |
| 10 | Structure Therapeutics | 8.43 Bn | 8.43 Bn | - | 5.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.56 Mn |
| Dec 31, 2025 | 717,000.00 |
| Sep 30, 2025 | 6.60 Mn |
| Jun 30, 2025 | 6.20 Mn |
| Mar 31, 2025 | 6.10 Mn |
| Dec 31, 2024 | 5.11 Mn |
| Sep 30, 2024 | 1.82 Mn |
| Jun 30, 2024 | 1.83 Mn |
| Mar 31, 2024 | 47,000.00 |
| Dec 31, 2023 | 45,000.00 |
| Sep 30, 2023 | 350,000.00 |
| Jun 30, 2023 | 38,000.00 |
| Mar 31, 2023 | 59,000.00 |
| Dec 31, 2022 | 3.46 Mn |